JAVMA news
FDA conditionally approves drug for treating lymphoma in dogs
The Food and Drug Administration announced Jan. 3 that it has conditionally approved Tanovea-CA1, or rabacfosadine, as the first animal drug to treat…
JAVMA news
Company takes canine cancer drug off market to study dosing
Oasmia Pharmaceutical AB has taken a canine cancer drug, Paccal Vet, or paclitaxel for injection, off the market to study lowering the
JAVMA news
New listings in AVMA Animal Health Studies Database
Below are some of the new listings of veterinary clinical studies in the AVMA Animal Health Studies Database.
JAVMA news
AVMA Animal Health Studies Database reaches 5 years, 500 listings
This June, the AVMA Animal Health Studies Database is marking the fifth anniversary of its launch. The AAHSD also recently surpassed 500 listings of…
AVMA news
NIH program in canine comparative oncology marks 20 years of progress
The National Institutes of Health created the Comparative Oncology Program two decades ago to advance the study of naturally occurring cancer in dogs,…
AVMA news
Cultivating research on cancer in dogs, from clinical trials down to the molecular level
The Comparative Oncology Program at the National Institutes of Health, which promotes the study of cancer in dogs, manages the Comparative Oncology…
AVMA news
Catalyzing the field of canine comparative oncology, benefiting researchers far and wide
The Comparative Oncology Program at the National Institutes of Health has transformed canine comparative oncology since the program’s founding 20…
AVMA news
New listings in AVMA Animal Health Studies Database – May 2023
The latest list of veterinary clinical studies in the AVMA Animal Health Studies Database (AAHSD) are available, including a study evaluating the…